301 related articles for article (PubMed ID: 3336347)
1. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
Stevens JC; Halpert J
Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
[TBL] [Abstract][Full Text] [Related]
2. Selective inactivation by chlorofluoroacetamides of the major phenobarbital-inducible form(s) of rat liver cytochrome P-450.
Halpert J; Jaw JY; Balfour C; Kaminsky LS
Drug Metab Dispos; 1990; 18(2):168-74. PubMed ID: 1971568
[TBL] [Abstract][Full Text] [Related]
3. Dichloromethyl compounds as mechanism-based inactivators of rat liver cytochromes P-450 in vitro.
Halpert JR; Balfour C; Miller NE; Kaminsky LS
Mol Pharmacol; 1986 Jul; 30(1):19-24. PubMed ID: 3724741
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
Miller NE; Halpert JR
Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
[TBL] [Abstract][Full Text] [Related]
5. Analogues of chloramphenicol as mechanism-based inactivators of rat liver cytochrome P-450: modifications of the propanediol side chain, the p-nitro group, and the dichloromethyl moiety.
Miller NE; Halpert J
Mol Pharmacol; 1986 Apr; 29(4):391-8. PubMed ID: 3702858
[TBL] [Abstract][Full Text] [Related]
6. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450.
Ciaccio PJ; Duignan DB; Halpert JR
Drug Metab Dispos; 1987; 15(6):852-6. PubMed ID: 2893713
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of cytochromes P450 2B protects against cocaine-mediated toxicity in rat liver slices.
Poet TS; Brendel K; Halpert JR
Toxicol Appl Pharmacol; 1994 May; 126(1):26-32. PubMed ID: 8184429
[TBL] [Abstract][Full Text] [Related]
8. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
Halpert J; Balfour C; Miller NE; Morgan ET; Dunbar D; Kaminsky LS
Mol Pharmacol; 1985 Sep; 28(3):290-6. PubMed ID: 4033629
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
10. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Escherichia coli-expressed rabbit cytochrome P-450 2C enzymes by 17 beta-substituted steroids.
Klekotka PA; Richardson TH; Johnson EF; Halpert JR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1450-5. PubMed ID: 7562521
[TBL] [Abstract][Full Text] [Related]
12. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
Murray M; Butler AM
J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177
[TBL] [Abstract][Full Text] [Related]
13. Selective inactivation of rat liver cytochromes P-450 by 21-chlorinated steroids.
Halpert J; Jaw JY; Cornfield LJ; Balfour C; Mash EA
Drug Metab Dispos; 1989; 17(1):26-31. PubMed ID: 2566465
[TBL] [Abstract][Full Text] [Related]
14. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
Ng SF; Waxman DJ
Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
[TBL] [Abstract][Full Text] [Related]
16. Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol.
Kraner JC; Morgan ET; Halpert JR
J Pharmacol Exp Ther; 1994 Sep; 270(3):1367-72. PubMed ID: 7932191
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations.
Waxman DJ; Lapenson DP; Park SS; Attisano C; Gelboin HV
Mol Pharmacol; 1987 Nov; 32(5):615-24. PubMed ID: 3119986
[TBL] [Abstract][Full Text] [Related]
18. Ring hydroxylation of [o-3H]methoxychlor as a probe for liver microsomal CYP2B activity: potential for in vivo CYP2B assay.
Stresser DM; Dehal SS; Kupfer D
Anal Biochem; 1996 Jan; 233(1):100-7. PubMed ID: 8789153
[TBL] [Abstract][Full Text] [Related]
19. Selectivity and kinetics of inactivation of rabbit hepatic cytochromes P450 2B4 and 2B5 by N-aralkylated derivatives of 1-aminobenzotriazole.
Grimm SW; Bend JR; Halpert JR
Drug Metab Dispos; 1995 May; 23(5):577-83. PubMed ID: 7587934
[TBL] [Abstract][Full Text] [Related]
20. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis.
Murray M; Zaluzny L; Dannan GA; Guengerich FP; Farrell GC
Mol Pharmacol; 1987 Jan; 31(1):117-21. PubMed ID: 3543647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
